// App-Quantinova.ai

732 : Progression of Skin Fibrosis Is Associated with Decline in Lung Function in Patients with Diffuse Cutaneous Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis

Researchers

Presenter

  • Wanlong Wu

Principal Investigators

  • Suzana Jordan

  • Nicole Graf

  • Janethe Pena

  • John Curram

  • Yannick Allanore

  • Marco Matucci-Cerinic

  • Janet E. Pope

  • Christopher Denton

  • Dinesh Khanna

  • Oliver Distler

Medical Centers

  • Department of Rheumatology and Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland

  • Department of Neurology, University Hospital Zurich, Zurich, Switzerland

  • graf biostatistics, Winterthur, Switzerland

  • Bayer HealthCare Pharmaceuticals, Whippany, NJ

  • Bayer Plc, Newbury, United Kingdom

  • Rheumatology Department, Cochin hospital, Paris-Descartes University, Paris, France

  • Dept of Medicine/Div of Rheum, University of Florence, Firenze, Italy

  • Department of Medicine, Division of Rheumatology, University of Western Ontario, St. Joseph’s Health Care, London, ON, Canada,

  • Department of Medical Oncology, University College London Hospital, London, United Kingdom

  • Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, United States.

Locations

  • Switzerland

  • United States

  • United Kingdom

  • France

  • Italy

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved